Sotera Health Company (SHC) shares soared 5.82% in pre-market trading on Monday, following a significant upgrade from Goldman Sachs. The investment bank raised its rating on Sotera Health from Neutral to Buy, sparking renewed investor interest in the company.

The upgrade from Goldman Sachs suggests a more optimistic outlook for Sotera Health's future performance. While specific details of the analyst's rationale were not immediately available, such upgrades are typically based on factors like improved financial prospects, market positioning, or industry trends that could benefit the company.

Sotera Health Company, a leading global provider of mission-critical sterilization and lab testing and advisory services to the medical device and pharmaceutical industries, has been attracting increased attention from investors and analysts alike. This latest upgrade could signal growing confidence in the company's strategic direction and growth potential in the healthcare sector.